Deep Brain Stimulation (DBS) Systems
Boston Scientific Corp · Decision date May 28, 2026
What did the FDA approve?
FDA records P150031/S092 as a supplement to PMA P150031, with the supplement type “Real-Time Process”. The recorded decision is approval, dated May 28, 2026.
FDA approval order statement
approval for change from the Surface Pro 6 (SP6) to Surface Pro 7 (SP7) as the off-the-shelf hardware used for the Clinician Programmer software
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Neurology
- Decision date
- May 28, 2026
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P150031/S092
- Regulatory pathway
- PMA supplement
- Applicant
- Boston Scientific Corp
- Product code
- NHL
- Decision code
- APPR
- Decision date
- May 28, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, electrical, implanted, for parkinsonian symptoms.
- Applicant
- Boston Scientific Corp
- Product code
- NHL
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P150031. Subsequent supplements may change the device or its indications.
FDA decision timeline
P150031 · Original PMA
VERCISE DEEP BRAIN STIMULATION (DBS)SYSTEM
P150031/S087 · Related supplement
Vercise Deep Brain Stimulation (DBS) Systems
P150031/S089 · Related supplement
Vercise Genus Deep Brain Stimulation (DBS) Systems
P150031/S090 · Related supplement
Vercise Deep Brain Stimulation (DBS) Systems
P150031/S091 · Related supplement
Vercise Deep Brain Stimulation (DBS) Systems
P150031/S092 received
Application receipt date recorded by FDA.
P150031/S093 · Related supplement
(Vercise Deep Brain Stimulation (DBS) Systems)
P150031/S094 · Related supplement
Vercise Deep Brain Stimulation (DBS) Systems
P150031/S092 · FDA decision
Real-Time Process
P150031/S095 · Related supplement
Vercise Deep Brain Stimulation (DBS) Systems
P150031/S096 · Related supplement
Vercise Deep Brain Stimulation (DBS) Systems
P150031/S097 · Related supplement
Vercise Deep Brain Stimulation (DBS) Systems
P150031/S084 · Related supplement
VERCISE DEEP BRAIN STIMULATION (DBS) SYSTEM
P150031/S098 · Related supplement
Vercise Genus DBS Systems; Vercise Gevia DBS Systems
P150031/S100 · Related supplement
Vercise DBS Systems
P150031/S102 · Related supplement
Vercise Deep Brain Stimulation (DBS) Systems
Timeline entries are records held by MedtechLedger for P150031. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150031
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific Corp
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- 25155 Rye Canyon Loop, Valencia, CA, 91355
Sources and methodology
- Original FDA record: P150031/S092
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

